Introduction
Buserelin is a gonadotrophin-releasing hormone (GnRH) analog, specifically an LHRH agonist. It acts on the pituitary gland, which regulates the production of various hormones. Buserelin alters hormone levels, particularly estrogen and androgen levels. This hormone manipulation is used to treat prostate cancer, as testosterone stimulates the growth of prostate tumors. Buserelin reduces testosterone levels, depriving the tumor of this hormone and causing it to shrink.
Description
Buserelin is a peptide composed of 9 amino acids: Glu-His-Trp-Ser-Tyr-D-Ser(tBu)-Leu-Arg-Pro-NHEt. It has a molecular weight of 1239.44 Daltons.
Physical Appearance
Sterile, white, lyophilized (freeze-dried) powder.
Formulation
The Buserelin peptide is lyophilized without any additives.
Solubility
Reconstitute the lyophilized Buserelin in sterile 18MΩ-cm H2O at a concentration of at least 100 µg/ml. This solution can be further diluted in other aqueous solutions.
Stability
Lyophilized Buserelin remains stable at room temperature for up to 3 weeks but should be stored desiccated below -18°C. After reconstitution, store Buserelin at 4°C for 2-7 days. For future use, store below -18°C. Adding a carrier protein (0.1% HSA or BSA) is recommended for long-term storage. Avoid freeze-thaw cycles.
Purity
Purity exceeds 98.0% as determined by:
(a) Reverse-phase high-performance liquid chromatography (RP-HPLC) analysis.
(b) Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis.